With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...

The FDA resolved the shortage of Eli Lilly's tirzepatide, but may revisit allowing compounding pharmacies to make copies, ...

Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of ...

Three Philadelphia nurses attempting to care for a gunshot victim were struck by the same vehicle that dropped off the ...

The UK has become a “relatively small market” since leaving the European Union and must develop a different investment ...

Harris is seeing an uptick in support from Black women voters who support her efforts to protect abortion and expand prenatal ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Lilly’s latest investment comes on the heels of three earlier rounds of manufacturing investment at the LEAP Research and ...

Five years ago, Viking Therapeutics (NASDAQ: VKTX) was an unknown, clinical-stage biotech. It hardly stood out in a sea of small drugmakers, and most of those never end up producing the kinds of ...

Presidential rivals stoke voter doubts   Which party will lead the Senate in 2025? Israel attacks U.N. peacekeepers in Lebanon “Chopsticks” could help SpaceX reuse rocket ...

Supergut, the only nutrition brand clinically-validated to improve digestive health and curb cravings, is rolling out ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.